A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.

Meetings designed to distribute grant money to fund research were canceled as part of a communications freeze at health agencies.

Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as scheduled, the agency’s acting director told staff scientists in an email Monday.

Just days after President Trump imposed broad restrictions on communications, meetings, travel and public appearances at the Department of Health and Human Services (HHS), the National Institutes of Health (NIH) is clarifying the extent of the freeze’s effect.

The Trump administration continues its deluge of executive orders that directly affect science and research, just days after being sworn in. Following the executive orders (EOs) taking the United States out of the Paris Agreement and World Health Organization and the scientific nonsense in the EO on trans and non-binary people,

The National Institutes of Health funds research, but some scientists fear that funding may be pulled or paused by the Trump administration.

A flurry of scientific gatherings and panels across federal science agencies were canceled on Wednesday, at a time of heightened sensitivity about how the

New rules include a hold on the review panels the National Institutes of Health uses to evaluate and approve research grants.

The first week of President Donald Trump’s second term included several executive orders and actions that will be detrimental to public health.

The halt has frozen research grants, meetings and key health updates. “Everything is basically in chaos,” said one cancer researcher.

The Trump administration’s freeze on communications from U.S. health agencies is leading to another disruption: the abrupt cancellation of scientific meetings. The move covers a swath of health conditions,

The administration of U.S. President Donald Trump has instructed federal health agencies to pause all external communications, such as health advisories, weekly scientific reports, updates to websites and social media posts,